<- Go Home
Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally. The company provides prescription drugs covering various therapeutic areas, including cardiovascular and cerebrovascular, hepato-biliary-pancreatic, respiratory system, diabetes, tumor immunity, gastrointestinal disease, gynecological, rheumatism, soothe the nerves, pruritus, and andrological areas, as well as over-the-counter drugs. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is headquartered in Tianjin, China.
Market Cap
CNY 24.2B
Volume
14.2M
Cash and Equivalents
CNY 2.4B
EBITDA
CNY 1.7B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CNY 5.7B
Profit Margin
66.80%
52 Week High
CNY 17.77
52 Week Low
CNY 12.69
Dividend
3.27%
Price / Book Value
2.03
Price / Earnings
24.81
Price / Tangible Book Value
2.13
Enterprise Value
CNY 22.7B
Enterprise Value / EBITDA
12.38
Operating Income
CNY 1.4B
Return on Equity
7.15%
Return on Assets
5.31
Cash and Short Term Investments
CNY 2.9B
Debt
CNY 1.3B
Equity
CNY 12.1B
Revenue
CNY 8.5B
Unlevered FCF
CNY 748.6M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium